(Q34461886)

2 August 2017

0 references

1 reference

title

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664494%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Catherine Elzerbi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664494%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Rob Saunders

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664494%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Craig J. Whittington

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664494%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Colin Drummond

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664494%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Stephen Pilling

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664494%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

English

0 references

publication date

17 March 2015

1 reference

2 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664494%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664494%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664494%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

920-930

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664494%20AND%20SRC:MED&resulttype=core&format=json

Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study

2 June 2020

cites work

1 reference

Endogenous opioids and addiction to alcohol and other drugs of abuse

21 January 2018

1 reference

Opioid antagonists for alcohol dependence

21 January 2018

1 reference

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis

21 January 2018

1 reference

Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

21 January 2018

1 reference

Acamprosate for alcohol dependence

21 January 2018

1 reference

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

21 January 2018

1 reference

Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.

21 January 2018

1 reference

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation

21 January 2018

1 reference

Predicting treatment response to naltrexone: the influence of craving and family history

21 January 2018

1 reference

Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

21 January 2018

1 reference

Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes

21 January 2018

1 reference

Going from evidence to recommendations

21 January 2018

1 reference

Efficacy of acamprosate in the treatment of alcohol-dependent outpatients

21 January 2018

1 reference

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

21 January 2018

1 reference

Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain

21 January 2018

1 reference

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

21 January 2018

1 reference

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence

21 January 2018

1 reference

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

21 January 2018

1 reference

Comparing topiramate with naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

21 January 2018

1 reference

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial

21 January 2018

1 reference

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

21 January 2018

1 reference

A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan

21 January 2018

1 reference

Effectiveness of naltrexone in a community treatment program

21 January 2018

1 reference

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

21 January 2018

1 reference

Naltrexone for alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.

21 January 2018

1 reference

A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention

21 January 2018

1 reference

A randomized clinical trial of naltrexone and behavioral therapy for problem drinking men who have sex with men.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ADD.12875

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25664494%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference